Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies

S Mahajan, M Aalhate, E Chatterjee, H Singh… - International Journal of …, 2024 - Elsevier
Duvelisib (DUV) is effective against numerous hematological malignancies; however, it
suffers from numerous setbacks like poor aqueous solubility, low cellular uptake and …

Advancing apoptosis induction in triple negative breast cancer: Empowering treatment with tyrosine-stapled mixed micelles of lapatinib

R Ghadi, A Wadikar, M Dharshini, V Yadav… - Journal of Molecular …, 2024 - Elsevier
The available treatment modalities for triple-negative breast cancer (TNBC) face several
challenges, including discouraging overall survival outcomes, unavoidable toxicities, and …

Co-Delivery of Glycyrrhizin and Paclitaxel via Gelatin-Based Core–Shell Nanoparticles Ameliorates 1, 2-Dimethylhydrazine-Induced Precancerous Lesions in Colon

MM Ansari, V Yadav, S Dighe, K Kuche… - ACS Biomaterials …, 2025 - ACS Publications
Colorectal cancer is a lethal malignancy that begins from acquired/inherent premalignant
lesions. Thus, targeting these lesions at an early stage of the disease could impede the …

Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancer

S Chandani, S Dighe, O Katari, V Yadav… - International Journal of …, 2025 - Elsevier
Bcl-2 protein plays an integral role in hijacking apoptosis and triggering chemoresistance in
triple negative breast cancer (TNBC). The present study explored the therapeutic efficacy of …

Biotin-stapled mixed micelles of lapatinib: Unleashing apoptosis power in triple-negative breast cancer

R Ghadi, A Gabhale, PK Pandey, A Muley… - Colloids and Surfaces A …, 2024 - Elsevier
The treatment options currently offered for triple-negative breast cancer (TNBC) encounter
numerous obstacles, including disappointing overall survival rates, unavoidable side effects …

Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer

L Bhute, S Dighe, O Katari, V Yadav, S Jain - AAPS PharmSciTech, 2025 - Springer
Triple negative breast cancer (TNBC) exhibits higher susceptibility towards oxaliplatin (OXA)
due to a faulty DNA damage repair system. However, the unfavorable physicochemical …